Priority 16 from the Hyperemesis Gravidarum PSP
|UNCERTAINTY: How does hyperemesis gravidarum impact on a person's (and their family's) quality of life? How does quality and efficacy of treatment impact that effect? (JLA PSP Priority 16)
|JLA question ID
|Not available for this PSP
Negative effects identified in a qualitative systematic review ref: Dean C, Bannigan K, Marsden J. Reviewing the effect of hyperemesis gravidarum on women’s lives and mental health. British Journal of Midwifery. 2018;26(2): Plus further studies since then add to evidence base. However, no evidence identified on how quality and efficacy of treatments mitigate or exacerbate the effect.
|Health Research Classification System category
|Reproductive health and childbirth
|Extra information provided by this PSP
|Original uncertainty examples
|What is the range of difference in quality of life for patients as linked to the medicines they are given?
|Patients x 3 ~ Healthcare professionals x 2 ~ Organisational representatives x 2
|PSP unique ID
|Total number of uncertainties identified by this PSP.
|65 (To see a full list of all uncertainties identified, please see the detailed spreadsheet held on the JLA website)
|Date of priority setting workshop
|9 October 2019